Higher income American households pay the most to finance the nation's health care system, but the burden of payments as a share of income is greatest among households with the lowest incomes, according to a new RAND Corporation ...
Jan 27, 2020
0
1
Medicare appears to be overpaying surgeons for many medical procedures, according to a new RAND Corporation analysis.
Jan 22, 2020
0
0
Results of a new study show that a large number of physicians in the US may have received marketing payments from pharmaceutical companies that produce stimulant medications. Led by researchers at Boston Medical Center's ...
Jan 21, 2020
0
2
More US patients with kidney failure started, stayed on, and switched to peritoneal dialysis following a payment policy implemented in 2011 by Medicare. The findings, which appear in an upcoming issue of CJASN, suggest that ...
Nov 21, 2019
0
2
(HealthDay)—The vast majority of group medical practices report that regulatory requirements, including prior authorization and quality payment programs, are burdensome, according to a survey released by the Medical Group ...
Nov 6, 2019
0
0
If Medicare capped funds for Graduate Medical Education (GME) at the rate of $150,000 per resident, the move would free up more than $1 billion a year, according to a study published today in JAMA Internal Medicine. Medicare ...
Oct 7, 2019
0
3
An interdisciplinary team of Indiana University scientists studying Medicare data have found an association between health care industry payments to medical providers for non-research expenses and what these providers charge ...
Sep 20, 2019
1
93
(HealthDay)—In 2017, about half of physician directors of National Cancer Institute (NCI)-designated cancer centers received industry payments, according to a research letter published online Aug. 5 in JAMA Internal Medicine.
Aug 15, 2019
0
0
Use of a class of pain drugs called gabapentinoids has increased more than three-fold between 2002 and 2015.
Jul 9, 2019
1
0
Pharmaceutical companies' payments to doctors may be influencing them to prescribe more expensive, brand-name versions of the pain drug gabapentin, a team of researchers report in the July 8 issue of JAMA Internal Medicine, ...
Jul 8, 2019
0
3
